Skip to main content

Social Media

Search query

About
Our medicines
- Reblozyl^®
Science & pipeline
- Pipeline
- Luspatercept
- Sotatercept
- ACE-1334
- Publications
Patients
Careers

Home

Pricing delayed by 20 minutes.

SEC Filings

Search query

About
Our medicines
- Reblozyl^®
Science & pipeline
- Pipeline
- Luspatercept
- Sotatercept
- ACE-1334
- Publications
Patients
Careers
Investors & Media

Home

Home

Please note: There are no SEC Filings available for 2005, 2007 and 2011.

Select Year: Filter filing type:

Date Filing Type Filing Description Download / View

Quick Links

SEC Filings
Investor FAQs
Quarterly Results
Events & Presentations

IR Contact

Jamie Bernard, IRC
Associate Director, Investor Relations
investor@acceleronpharma.com

Media Contact

Matt Fearer
Director, Corporate Communications
mfearer@acceleronpharma.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Acceleron Pharma Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Acceleron Pharma Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options *

General Releases

Calendar Events

Quarterly and Annual Reports

All SEC Filings

End of Day Stock Quote

Unsubscribe

Email Alert Sign Up Confirmation

128 Sidney Street

Cambridge, MA 02139

Tel: (617) 649-9200

Breakthrough Drug of the Year

© Acceleron Pharma, Inc. All Rights Reserved.

Powered By Q4 Inc. 5.49.0.3 (opens in new window)

Sitemap
Community Guidelines
Privacy Policy